Suppr超能文献

国际多中心注册研究中的可穿戴式除颤器的真实临床经验。

Real life experience with the wearable cardioverter-defibrillator in an international multicenter Registry.

机构信息

Bergmannsheil University Medical Center, Ruhr University Bochum, Bochum, Germany.

Department of Cardiology and Angiology, Bergmannsheil University Hospitals, Ruhr University of Bochum, Bochum, Germany.

出版信息

Sci Rep. 2022 Feb 25;12(1):3203. doi: 10.1038/s41598-022-06007-y.

Abstract

Patients at high risk for sudden cardiac death (SCD) may benefit from wearable cardioverter defibrillators (WCD) by avoiding immediate implantable cardioverter defibrillator (ICD) implantation. Different factors play an important role including patient selection, compliance and optimal drug treatment. We aimed to present real world data from 4 centers from Germany and Switzerland. Between 04/2012 and 03/2019, 708 patients were included in this registry. Patients were followed up over a mean time of 28 ± 35.5 months. Outcome data including gender differences and different etiologies of cardiomyopathy were analyzed. Out of 708 patients (81.8% males, mean age 61.0 ± 14.6), 44.6% of patients had non-ischemic cardiomyopathy, 39.8% ischemic cardiomyopathy, 7.9% myocarditis, 5.4% prior need for ICD explantation and 2.1% channelopathy. The mean wear time of WCD was 21.2 ± 4.3 h per day. In 46% of patients, left ventricular ejection fraction (LVEF) was > 35% during follow-up. The younger the patient was, the higher the LVEF and the lower the wear hours per day were. The total shock rate during follow-up was 2.7%. Whereas an appropriate WCD shock was documented in 16 patients (2.2%), 3 patients received an inappropriate ICD shock (0.5%). During follow-up, implantation of a cardiac implantable electronic device was carried out in 34.5% of patients. When comparing German patients (n = 516) to Swiss patients (n = 192), Swiss patients presented with longer wear days (70.72 ± 49.47 days versus 58.06 ± 40.45 days; p = 0.001) and a higher ICD implantation rate compared to German patients (48.4% versus 29.3%; p = 0.001), although LVEF at follow-up was similar between both groups. Young age is a negative independent predictor for the compliance in this large registry. The most common indication for WCD was non-ischemic cardiomyopathy followed by ischemic cardiomyopathy. The compliance rate was generally high with a decrease of wear hours per day at younger age. Slight differences were found between Swiss and German patients, which might be related to differences in mentality for ICD implantation.

摘要

患者发生心源性猝死(SCD)的风险较高,通过避免立即植入植入式心律转复除颤器(ICD),可能受益于穿戴式心律转复除颤器(WCD)。包括患者选择、依从性和最佳药物治疗在内的不同因素发挥着重要作用。我们旨在呈现来自德国和瑞士 4 家中心的真实世界数据。在 2012 年 4 月至 2019 年 3 月期间,该登记处共纳入 708 例患者。这些患者的平均随访时间为 28 ± 35.5 个月。分析了包括性别差异和不同病因心肌病在内的预后数据。在 708 例患者(81.8%为男性,平均年龄 61.0 ± 14.6)中,44.6%的患者患有非缺血性心肌病,39.8%的患者患有缺血性心肌病,7.9%的患者患有心肌炎,5.4%的患者曾需要 ICD 取出,2.1%的患者患有通道病。WCD 的平均佩戴时间为每天 21.2 ± 4.3 小时。在随访期间,46%的患者左心室射血分数(LVEF)>35%。患者越年轻,LVEF 越高,每天佩戴时间越短。随访期间总的电击率为 2.7%。虽然在 16 例患者(2.2%)中记录到适当的 WCD 电击,但 3 例患者(0.5%)接受了不适当的 ICD 电击。在随访期间,34.5%的患者植入了心脏植入式电子设备。与德国患者(n=516)相比,瑞士患者(n=192)佩戴时间更长(70.72±49.47 天与 58.06±40.45 天;p=0.001),ICD 植入率也更高(48.4%与 29.3%;p=0.001),尽管两组的随访时 LVEF 相似。在这个大型登记处,年龄较轻是依从性的负独立预测因素。WCD 的最常见适应证是非缺血性心肌病,其次是缺血性心肌病。依从率总体较高,随着年龄的降低,每天佩戴时间减少。瑞士患者和德国患者之间存在细微差异,这可能与 ICD 植入观念的差异有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e3a6/8881447/d03f9358e49a/41598_2022_6007_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验